Bring On the Peanuts: Food Allergy Therapies Move Closer to Approval

Fifteen years after an experimental peanut allergy shot killed one patient, researchers have ramped up the science to find alternative treatments, including protein powders and herbal mixtures















Share on Tumblr

peanut food allergy

Spoonful of danger?: Experimental therapies are helping many children with severe food allergies eat peanut butter or milk without getting sick. But are the treatments ready for the millions of eager, allergic patients? Image: iStockphoto/Fertnig

The tableau is common enough these days: after a miscalculated meal, snack or sip, a parent rummages frantically for an EpiPen or antihistamine as a swollen-mouthed child sits, frightened, possibly gasping for breath.

The prevalence of food allergies has shot up in recent years and now affects some 8 percent of children in the U.S. And of the approximately six million kids who have food allergies in this country, more than a third (38.7 percent) have severe reactions. These responses, triggered by an immune system over-reaction, can lead to anaphylaxis, a systemic response that, if untreated, can be fatal.

With so many people just a bite or a drop away from a potentially deadly allergic reaction—and the cost of treatment for these allergies spiraling to about half a billion dollars in 2007—scientists have cast a wide net in the search for new and more effective ways to eliminate food allergies and have pulled in some promising approaches.  Potential therapies—including peanut protein powders and mixes of traditional Chinese herbs—are moving quickly through clinical trials, and some might be ready for regulatory evaluation within a year.

Down the hatch and under the tongue
Shots for pollen and other airborne allergens have been around for decades. So, as food allergy rates started to rise a couple of decades ago, researchers got to work adapting this principle for the new set of patients. In 1996 12 people with severe peanut allergies entered a clinical trial studying an injectable vaccine. One child in the study, however, had a severe reaction to the shot and died, making many people wary of the field altogether.

But the growing number of people with food allergies has been reigniting interest. Newer research has moved on to therapies that adults and kids can take orally—many as a powder that can be mixed into juice or a snack, such as applesauce. Other candidates include drops that are placed under the tongue (and held there for a couple minutes before being swallowed).

The principle is simple enough: slowly acclimate the immune system to the offending protein starting with minute doses. The very first dose of an experimental oral peanut allergy therapy, for example, might include about one one-thousandth the amount of peanut protein as is found in a whole nut.

Over weeks and months, the quantity of the protein is slowly ramped up. "With the repeated administration of the dosing, your immune system begins to change," explains Wesley Burks, the chief of Pediatric Allergy and Immunology at Duke University. For most people in the trials (which have each generally enrolled fewer than 30 subjects so far), their immune system starts to accept larger and larger quantities of the noxious protein. And after several months many previously allergic kids can eat a tablespoon of peanut butter without ill effect.

These oral-base therapies hold the most promise, says Robert Wood, chief of Allergy and Immunology at Johns Hopkins Children's Center. He notes that a return to the injectable vaccine is still tentative (even though many speculate that the previous fatality was likely the result of a dosing error). Wood's research has focused on milk allergies and has had especially promising results from powder formulas—in large part because of the administration route. He and his team have been able to work subjects up to as many as 2,000 milligrams of milk protein via that method, whereas the below-the-tongue approach has only reached about seven milligrams of the extract. (As he points out: "you can only put so much liquid under a person's tongue and have them hold it there.")

The body allergic
Just how the oral approach works is still somewhat of a puzzle for researchers, especially when compared with shots. Allergy injections introduce low levels of the offending protein (called an antigen) in the neighborhood of 10 to 100 micrograms to acclimate the body to the antigen's presence.

But for the oral therapies in development for peanut, milk and other food allergies, doses are higher, with as much as whole grams of an antigen in them. So in the body's response to them, "It's possible that the mechanisms are different," explains Dale Umetsu of the Children's Hospital Boston and Harvard Medical School's Division of Immunology. In mouse studies higher doses of antigen seem to actually trigger eventual deletions or reductions of the immune cells that target the antigen. After an initial rise the antigens linked to the protein slowly starts to decrease, lessening the chances of an over-reaction. "So there's definitely immunological changes, but exactly how this works is not clear," he says.



Rights & Permissions

4 Comments

Add Comment
View
  1. 1. maryesselmanroberts 09:29 AM 7/1/11

    The article mentions sublingual immunotherapy (drops under the tongue) but does not seem to elaborate -- I would be interested in hearing more about this option and am curious to know if the author interviewed anyone who is administering or receiving this treatment.

    Reply | Report Abuse | Link to this
  2. 2. Scientific American Reader in reply to maryesselmanroberts 01:06 PM 7/1/11

    From the research I've done on SLIT (sublingual immunotherapy), it is not FDA approved yet, so insurance does not cover them. They seem to be beneficial in treating food, seasonal allergies & asthma. They are not a cure, but, from what research shows, they may be aid in decreasing the severity of an allergy. Sounds like they would at least offer some protection against accidental ingestion.

    Some articles on SLIT:

    http://www.allergymoms.com/modules/wordpress/index.php?p=853

    http://www.allergymoms.com/modules/wordpress/index.php?p=912

    http://www.achooallergy.com/slit-allergy-cure.asp

    To find a SLIT provider, you can visit: www.allergychoices.com. Lacrosse Allergy of Wisconsin (www.lacrosseallergy.com) is the largest provider in the U.S.

    I don’t know how long it will be before they are FDA approved, but I hope it is soon. This therapy looks very promising!

    Reply | Report Abuse | Link to this
  3. 3. Wayne Williamson 06:46 PM 7/8/11

    Over the last several years I've become allergic to peanuts(one of my favorite things to eat)...one thing I've noticed is that the peanuts are very different from what they used to be in both shape and taste...anybody else notice this...just wondering...

    Reply | Report Abuse | Link to this
  4. 4. Allergy Mom 07:59 AM 7/16/11

    Why was there no mention of the skin patch treatment, which is being viewed as a potential cure and is currently in trials in the UK? http://www.telegraph.co.uk/health/healthnews/8544761/Skin-patch-could-cure-peanut-allergy.html

    Reply | Report Abuse | Link to this
Leave this field empty

Add a Comment

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.

More from Scientific American

See what we're tweeting about

Scientific American Editors

Tweets could not be retrieved at this time

Free Newsletters


Get the best from Scientific American in your inbox

Solve Innovation Challenges

Powered By: Innocentive

  SA Digital
  SA Digital

Science Jobs of the Week

Email this Article

Bring On the Peanuts: Food Allergy Therapies Move Closer to Approval

X
Scientific American MIND iPad

Tap into your MIND

Get Both Print & Tablet Editions for one low price!

Subscribe Now >>

X

Please Log In

Forgot: Password

X

Account Linking

Welcome, . Do you have an existing ScientificAmerican.com account?

Yes, please link my existing account with for quick, secure access.



Forgot Password?

No, I would like to create a new account with my profile information.

Create Account
X

Report Abuse

Are you sure?

X

Institutional Access

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com. To access this article in its entirety through site license access, click below.

Site license access
X

Error

X

Share this Article

X